Perhaps the search began with a name. A care conversation can begin with what has been bothering you instead.
Name the concern in ordinary words
Describe what you have noticed and what you hope to understand. Bring any past test reports you want to discuss. Make a note of medicines and supplements so you do not have to recall them on the spot.
There is no need to name a medical cause yourself. Leave space for the clinician to ask what else matters.
Ask what supports the proposed choice
As of September 30, 2026, a clinician had no FDA-approved instructions for using MOTS-c. There were no published results from treating people with MOTS-c itself. Long-term treatment results were also missing. A
Ask what evidence relates to your concern. Ask what the clinician would need to learn before suggesting any next step.
Keep other choices in the conversation
The FDA, which reviews US medicines, noted approved treatments for obesity and weak bones in material checked September 30, 2026. A
Obesity is a medical term for excess body fat. If weight or bone health is your concern, ask which choices have evidence that fits your situation.
You can ask why a proposed choice is being discussed, and what other approach might address the same concern.
Ask how the conversation continues
Before the visit ends, ask how to send a later question. Ask what any follow-up would look at, who would review it and how the cost would be explained.
If an answer contains an unfamiliar word, ask for it again in ordinary language. You are allowed to leave with questions answered in words you can use.
Carry this with you
Start with your concern. Ask about evidence, other choices and the next conversation before deciding anything.
Source notes for this page
The FDA review explains what is still unknown about giving MOTS-c to people. It also notes approved medicines for obesity and weak bones.